Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth (2021)

Peer-Reviewed Study · Zhou S, Wu H, Ning W, Wu X, Xu X, Ma Y, Li X, Hu J, Wang C, Wang J · August 13, 2021

Zhou S et al., 2021-08-13: Colorectal cancer cell study: ivermectin inhibited SW480 and SW1116 growth dose-dependently via ROS-mediated mitochondrial apoptosis, with S-phase arrest at 2.5-5 micromolar.

ivermectin dose-dependently inhibited colorectal cancer SW480 and SW1116 cell growth, followed by promoting cell apoptosis and increasing Caspase-3/7 activity

Zhou S et al., 2021-08-13: Colorectal cancer cell study: ivermectin inhibited SW480 and SW1116 growth dose-dependently via ROS-mediated mitochondrial apoptosis, with S-phase arrest at 2.5-5 micromolar. C7 colorectal cancer. Study type: cell lines only (SW480, SW1116); no animals, no patients. Country: China (Henan University, Kaifeng). Concentrations: low doses 2.5 and 5 uM induced arrest; higher doses dose-dependently killed. Funder/conflicts: 'The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.' Comparator: untreated cells and NAC rescue. No human data. Study type: lab.